FIELD: medicine, pharmaceutics.
SUBSTANCE: present inventions refers to a new crystalline form of tetomilast hydrate of the X-ray powder diffraction spectrum having characteristic peaks at the angle 20=10.6°, 12.9°, 21.1°, 22.3° and 25.0°, to a new crystalline form of anhydrous tetomilast type C of the X-ray powder diffraction spectrum having characteristic peaks at the angle 2θ=4.2°, 8.2°, 12.0°, 16.4°, 24.7° and 25.9°, to a new crystalline form of acetonitrile tetomilast solvate of the X-ray powder diffraction spectrum having characteristic peaks at the angle 2θ=3.6°, 7.1°, 10.6°, 14.2° and 24.8°, to based pharmaceutical compositions and to methods for preparing.
EFFECT: new crystalline forms shows useful processing characteristics with relation to preparing pharmaceutical drugs of them.
13 cl, 14 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TETOMILAST POLYMORPHS | 2007 |
|
RU2408597C2 |
| ARIPIPRAZOLE MEDICINAL AGENT OF LOW HYGROSCOPICITY AND METHODS FOR ITS PREPARING | 2002 |
|
RU2279429C2 |
| LOW HYGROSCOPICITY ARYPYPRAZOLE MEDICINAL AGENT AND METHODS FOR ITS PREPARING | 2002 |
|
RU2259366C2 |
| CRYSTALLINE FORM OF DERIVATIVE OF 1,2-DIHYDROPYRIDINE AND METHOD FOR PREPARATION THEREOF | 2005 |
|
RU2323930C1 |
| ROMIDEPSIN SOLID FORMS AND USE THEREOF | 2011 |
|
RU2607634C2 |
| POLYMORPHOUS FORMS OF 1-[4-(5-CYANOINDOLE-3-YL)BUTYL]-4-(2-CARBAMOYLBENOFURAN-5-YL)-PIPERAZINE HYDROCHLORIDE | 2002 |
|
RU2303598C2 |
| AZOBENZENE DERIVATIVE AND CRYSTALLINE FORM THEREOF | 2015 |
|
RU2701515C2 |
| POLYMORPHIC FORM OF SODIUM HYODEOXYCHOLATE (NAHDC) AND PREPARATION PROCESS THEREOF | 2014 |
|
RU2669785C2 |
| STABLE MODIFICATIONS OF TEGASEROD HYDROMALEATE | 2004 |
|
RU2349585C2 |
| CO-CRYSTALLINE FORMS OF TRAMADOL AND NSAID | 2009 |
|
RU2599717C2 |
